Hydroxyurea
Hydroxyurea has been studied in 9 papers since 2018: 2 observational studies in people, 1 in animals, 4 in cells, 2 reviews; 5 in the past year. The newest paper, Oct 25, 2026: “Management of Elderly and Frail Patients with Philadelphia-Negative Myeloproliferative Neoplasms—A Narrative Review”.
1 new paper in 30 daysSee all 33 papers on hydroxyurea
At a glance
The findings reach people, from one lab or study; independent labs found the same change in cells. 6 independent labs in 4 countries; 144 trials, 55 with no results posted.
“CH was not associated with exposure to hydroxyurea therapy (OR, 0.76; P = .44)”
None of its findings points the other way.
- 6 independent labs in 4 countries
- 144 trials, 55 with no results posted
- Funders: National Heart, Lung, and Blood Institute and others
- 1 of 6 findings with company ties
- 5 of 144 trials sponsored by its developers
- Humans2
- Animals1
- Cells4
What did studies of hydroxyurea find?
4Studies of hydroxyurea measured 4 outcomes, among them cellular senescence, clonal hematopoiesis of indeterminate potential and MCC vacuolation.
Cellular senescence
upin human cells1upin mouse cells1
2 studies
Cellular senescence
upin human cells1upin mouse cells1
Hydroxyurea induces cellular senescence in HK-2 proximal tubular cells (greatest fold-changes).
Cellsin HK-2 proximal tubular cells100 μM
Hydroxyurea increases cellular senescence in Polb-null mouse embryonic fibroblasts, compared with wild-type treated with hydroxyurea.
Cellsin Polb-null mouse embryonic fibroblasts, compared with wild-type treated with hydroxyurea
Clonal hematopoiesis of indeterminate potential
no changein humans1OR 0.76
1 study
Clonal hematopoiesis of indeterminate potential
no changein humans1OR 0.76
Hydroxyurea was not clearly linked with clonal hematopoiesis of indeterminate potential in humans (children with sickle cell disease) (OR 0.76; P = .44).
Humanschildren with sickle cell disease
MCC vacuolation
upin mouse cells1
1 study
MCC vacuolation
upin mouse cells1
Hydroxyurea induces MCC vacuolation in vitro organotypic culture.
Cellsin vitro organotypic culture
Chronological lifespan
upin yeast cells1
1 study
Chronological lifespan
upin yeast cells1
Hydroxyurea extends chronological lifespan in yeast cells (exposure during growth, but not during stationary phase).
Cellsexposure during growth, but not during stationary phaselow doses
What is hydroxyurea linked with?
1Studies link hydroxyurea with telomere length.
Telomere length
downin humans1
1 study
Telomere length
downin humans1
Hydroxyurea is associated with telomere length in humans (sickle cell disease; multivariate analysis; possible confounding by disease severity) (β = -0.194, 95% CI -0.250 to -0.138; p < 0.001).
Humanssickle cell disease; multivariate analysis; possible confounding by disease severityleukocyten = 2,620
Trial sponsors
Company5 trialsPhase 4237 people
Company1 trialPhase 4150 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 476 people
Company1 trialPhase 3222 people
Company2 trialsPhase 250 people
Company1 trialPhase 2231 people
Company1 trialPhase 2230 people
Company1 trialPhase 267 people